International Journal of Pharma and Bio Sciences
    ISSN 0975-6299

Int J Pharm Bio Sci Volume 13 Issue 1, January - March, Pages:103-108

Role of Molecular Identification for Treatment of Highly Fatal Invasive Mucormycosis: A Meta-Analysis

Saurabh Jain, Uditkumar Agrawal, Vaibhav Agrawal, Swapnil Patond and Sanjay Agrawal

India, in the last couple of years has seen surging cases of raging mucormycosis causing invasive mold infections in patients on corticosteroid therapy, those immunosuppressed and unfortunate sufferers of diabetic ketoacidosis. We all are apprised, that Rhizopus is the most common etiologic agent for Rhino-cerebral symptoms; the prevalent clinical manifestation of mucormycosis. To pinpoint Mucorales in general, we hitherto exploit the phenotypic methods like Histopathology and culture. It's noteworthy, that both these modalities have some constraints. Their low sensitivity and specificity is attributed to common morphology of Mucorales. Momentum of molecular diagnosis, coupled with high specificity and sensitivity for species level identification, is enhanced by using semi-nested PCR with Mucorales specific primers as well as PCR with High Resolution Melting Analysis (HRMA). Liposomal Amphotericin-B has an edge over multitudes of antifungals; but for its toxicity. To analyze the role of Molecular identification for treatment of highly fatal mucormycosis, a total of 25 articles were selected for meta-analysis, the source being Pubmed and Google scholar. A Korean study of Mina Yang, M.D. et al found, species level identification is only 25 % by phenotypic method. Sarah P. Hammond et al Phenotypically identified 12 (44.44%) & Genotypically 22 (81.48%) out of 27 clinical cases of mucormycosis. This review covers an implementation of molecular methods using semi-nested PCR with Mucorales specific primers and PCR/High Resolution Met Analysis (HRMA), as routine identification for Mucorales, that was missed by some articles. Most of the early published review studies focused on phenotypic and molecule for identification of the fungal infection, but rarely on availability of molecular methods, so by proper awareness about availability of molecular methods and its use, the management of Mucormycosis and its mortality effects can be reduced.

Keywords: Mucorales, clinical scenario, phenotypic identification, molecular identification and antifungal.
Full HTML:


  1. Skiada A, Lass-Floerl C, Klimko N,Ibrahim A, Roilides E, Petrikkos G. Challenges in the diagnosis and treatment of mucormycosis. ISHAM Medical Mycology 2018;56:93–101.
  2. Wagner L, Hoog S, Alastruey-Izquierdo A, Voigt K, Kurzai O, Walthera G. A Revised Species Concept for Opportunistic Mucor Species Reveals Species-Specific Antifungal Susceptibility Profiles. American society of Microbiology Antimicrobial Agents and Chemotherapy 2019; 63(8):653-19.
  3. MinaYang M M.D, JangHoLee MT, Young-Kwon Kim MT, Chang-Seok Ki MD, HeeJaeHuh MD, NamYongLee  MD. Identification of Mucorales From Clinical Specimens: A 4-Year Experience in a Single Institution. Annals of Laboratory Medicine 2016;36:60-63.
  4. Skiada A, Pavleas I , Drogari-Apiranthitou M. Epidemiology and Diagnosis of Mucormycosis: An Update. Journal of Fungi 2020; 6: 265.
  5. Machouart M, Larche J , Burton K,  Collomb J, Maurer P, Cintrat A, Biava MF, Greciano S, Kuijpers AFA, Contet-Audonneau N, Hoog GS, Ge´rard A, Fortier B. Genetic Identification of the Main Opportunistic Mucorales by PCR-Restriction Fragment Length Polymorphism. Journal of Clinical Microbiology 2006; 44(3): 805–810.
  6. Singh S, Pal N, Chander J, Sardana R, Mahajan B, Joseph N, Chakrabarti A, Rudramurthy SM, Hariprasath P, Paul S, Kaur H, Ghosh A. Mucormycosis caused by Syncephalastrum spp.: Clinical profile, molecular characterization, antifungal susceptibility and review of literature. Clinical Infection in Practice 2021; 11:100074.
  7. Eshkaleti MN, Hashemi SJ, Falahati M, Mahmoudi S, Zaini F, Mirhendi H, Safara M, Shoar MG, Kordbacheh P. Molecular Identification of Causative Agents in 25 Cases with Mucormycosis in Iran. Arch Clin Infect Dis 2019; 14(1):e69100.
  8. Cornely OA, Arikan-Akdagli S, Dannaoui E, Groll AH, Lagrou K, Chakrabarti A, Lanternier F,  Pagano L. ESCMID and ECMM joint clinical guidelines for the diagnosis andmanagement of mucormycosis. Clincal Microbiology Infection 2014; 20(3): 5–26.
  9. Hrncirova K, Lengerova M, Kocmanova I, Racil Z, Volfova P, Palousova D, Moulis M, Weinbergerova B, Winterova J, Toskova M, Pospisilova S, Mayer J. Rapid Detection and Identification of Mucormycetes from Culture and Tissue Samples by Use of High-Resolution Melt Analysis. Journal of Clinical Microbiology 2010;48(9):3392–3394.
  10. Zaman K, Rudramurthy SM, Das A, Panda N, Honnavar P, Kaur H, Chakrabarti A. Molecular diagnosis of rhino-orbito-cerebral mucormycosis from fresh tissue samples. Journal of Medical Microbiology 2017;66:1124–1129.
  11. Ganesan A, Wells J, Shaikh F, Peterson P, Bradley W, Carson ML, Petfield JL, Fischer MK, Akers KS, Downing K, Bialek R, Tribble DR, Wickesi BL. Molecular Detection of Filamentous Fungi in Formalin-Fixed Paraffin-Embedded Specimens in Invasive Fungal Wound Infections Is Feasible with High Specificity. Journal of Clinical Microbiology 2020; 58(1):1259-19.
  12. Sigera LSM, Gamage KKK, Jayawardena MN,  Abeydeera WPH, Malkanthi MA, Jayasekera PI, Patabendige CGUA, Fernando AHN. Cutaneous mucormycosis caused by Saksenaea vasiformis in a patient with systemic lupus erythematosus. Clincal Case Repiratory 2018;6:1730–1734.
  13. Skiada A, Pavleas I and Drogari-Apiranthitou M. Rare fungal infectious agents: a lurking enemy. F1000Research 2017, 6(F1000 Faculty Rev):1917.
  14. Bialek R, Konrad F, Kern J, Aepinus C, Cecenas L, Gonzalez GM, Just-Nubling G, Willinger B, Presterl E, Lass-Florl C, Rickerts V. PCR based identification and discrimination of agents of mucormycosis and aspergillosis in paraffin wax embedded tissue. Journal Clinical Pathology 2005;58:1180–1184.
  15. Hammond SP, Bialek R, Milner DA, Petschnigg EM, Baden LR, Marty FM. Molecular Methods To Improve Diagnosis and Identification of Mucormycosis. Journal of Clinical Microbiology 2011;49(6): 2151–2153.
  16. Hofman V, Dhouibi A, Butori C, Padovani B, Toussaint M, Hermoso DG, Baumann M, Venissac N, Cathomas G, Hofman P. Usefulness of molecular biology performed with formaldehyde-fixed paraffin embedded tissue for the diagnosis of combined pulmonary invasive mucormycosis and aspergillosis in an immunocompromised patient. Diagnostic Pathology 2010;5:1.
  17. Lengerova M, Racil Z, Hrncirova K, Kocmanova I, Volfova P, Ricna D, Bejdak P, Moulis M, Pavlovsky Z, Weinbergerova B, Toskova M, Mayer J. Rapid Detection and Identification of Mucormycetes in Bronchoalveolar Lavage Samples from Immunocompromised Patients with Pulmonary Infiltrates by Use of High-Resolution Melt Analysis. Journal of Clinical Microbiology 2014;52(8): 2824–2828.
  18. Guinea J, Escribano P, Vena A, Muñoz P, Jimeanez M, Padilla B, Bouza E. Increasing incidence of mucormycosis in a large Spanish hospital from 2007 to 2015: Epidemiology and microbiological characterization of the isolates. PLOS ONE 2017;12(6): e0179136.
  19. Ikeda K, Monden T, Kanoh T, Tsujie M, Izawa H, Haba A, Ohnishi T, Sekimoto M, Tomita N, Shiozaki H, Monden M. Extraction and analysis of diagnostically useful proteins from formalin-fixed, paraffin embedded tissue sections. J Histochem Cytochem 1998;46:397– 403.
  20. Jang JH, Lee JH, Ki CS, Lee NY. Identification of clinical mold isolates by sequence analysis of the internal transcribed spacer region, ribosomal large-subunit D1/D2, and β-tubulin. Ann Lab Med 2012;32:126-32.
  21. Schwarz P, Bretagne S, Gantier JC, Garcia-Hermoso D, Lortholary O, Dromer F. Molecular identification of zygomycetes from culture and experimentally infected tissues. J Clin Microbiol 2006;44:340-9.
  22. Pham AS, Tarrand JJ, May GS, Lee MS, Kontoyiannis DP, Han XY. Diagnosis of invasive mold infection by real-time quantitative PCR. Am J Clin Pathol 2003; 119:38-44.
  23. Francesconi A, Kasai M, Harrington SM, Beveridge MG, Petraitiene R, Petraitis V, Schaufele RL, Walsh TJ. Automated and manual methods of DNA extraction for Aspergillus fumigatus and Rhizopus oryzae analyzed by quantitative real-time pCR. J. Clin. Microbiol. 200846:1978–1984.
  24. Rickerts V, Nubling GJ,  Konrad F , Kern J, Lambrecht E, Bohme A, Jacobi V, Bialek R. Diagnosis of invasive aspergillosis and mucormycosis in immunocompromised patients by seminested PCR assay of tissue samples. Eur. J. Clin. Microbiol. Infect. Dis.2006; 25:8–13.
  25. Zhang G, Zhang S, Wang Z, Zhu Y, Kong J,Huang L, Guo Y,  Wang Y , Zou R, Xie C. Fatal and Rapid Progressive Isolated Cerebral Mucormycosis Involving the Bilateral Basal Ganglia: A Case Report. Frontiers in Neurology 2020;11:295
[Download PDF]
Welcome to IJPBS,Pharmaceutics, Novel, drug, delivery, system, Nanotechnology, Pharmacology, Pharmacognosy
Pharmaceutical Fields
Welcome to IJPBS,Pharmaceutics, Novel, drug, delivery, system, Nanotechnology, Pharmacology, Pharmacognosy Pharmaceutics
Welcome to IJPBS,Pharmaceutics, Novel, drug, delivery, system, Nanotechnology, Pharmacology, Pharmacognosy Novel drug delivery system
Welcome to IJPBS,Pharmaceutics, Novel, drug, delivery, system, Nanotechnology, Pharmacology, Pharmacognosy Nanotechnology
Welcome to IJPBS,Pharmaceutics, Novel, drug, delivery, system, Nanotechnology, Pharmacology, Pharmacognosy Pharmacology
Welcome to IJPBS,Pharmaceutics, Novel, drug, delivery, system, Nanotechnology, Pharmacology, Pharmacognosy Pharmacognosy
© Copyright 2009-2015 IJPBS, India. All rights reserved. Specialized online journals by ubijournal. Website by Ubitech Solutions
         Home I Contact I Terms & Conditions